TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35325257

Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg oral dose)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 36123066

Group type: EXPERIMENTAL
Intervention: Email-based nudges based on peer behaviour
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Email-based nudges based on best practice guidelines
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no nudges)
Number of subjects: 19
Study: 33913765

Group type: EXPERIMENTAL
Intervention: Postpartum DMPA administration
Number of subjects: 170

Group type: COMPARATOR
Intervention: No DMPA administration (Control)
Number of subjects: 170
Study: 35869741

Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (FCM)
Number of subjects: 1082

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1082
Study: 32885541

Group type: EXPERIMENTAL
Intervention: E‐AR cream containing GSH‐C4 (0.1%), beta‐Glycyrrhetic (0.5%), and azelaic acids (10%) applied daily for 8 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: E‐AR cream
Number of subjects: 30
Study: 36307922

Group type: EXPERIMENTAL
Intervention: CETP inhibitor TA-8995 (obicetrapib)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Friedewald equation
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Martin/Hopkins equation
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Sampson equation
Number of subjects: 242
Study: 33155876

Group type: EXPERIMENTAL
Intervention: DNC
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: DNC-R
Number of subjects: 200

Group type: COMPARATOR
Intervention: HTK
Number of subjects: 200

Group type: COMPARATOR
Intervention: HTK-R
Number of subjects: 200
Study: 32948577

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine or chloroquine
Number of subjects: 200000

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 200000

Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Number of subjects: 200000

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir
Number of subjects: 200000

Group type: EXPERIMENTAL
Intervention: Stem cell treatments
Number of subjects: 200000

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 200000
Study: 34295867

Group type: EXPERIMENTAL
Intervention: Protective gear
Number of subjects: 65

Group type: COMPARATOR
Intervention: Civilian clothes (Control)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 65
Study: 33139709

Group type: EXPERIMENTAL
Intervention: Dynamic faces (happy, angry)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Dynamic flowers
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Processing happy compared to angry faces
Number of subjects: 222
Study: 34146521

Group type: EXPERIMENTAL
Intervention: HF-DMP
Number of subjects: 671

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 671
Study: 33882913

Group type: EXPERIMENTAL
Intervention: mini-CEX assessments
Number of subjects: 38

Group type: COMPARATOR
Intervention: ad-hoc feedback
Number of subjects: 38
Study: 33575846

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Adjuvant Radiotherapy (RT)
Number of subjects: 442

Group type: COMPARATOR
Intervention: Adjuvant treatment (RT or RCT)
Number of subjects: 442

Group type: COMPARATOR
Intervention: Adjuvant radio(chemo)therapy (RCT and RT)
Number of subjects: 442

Group type: COMPARATOR
Intervention: No adjuvant therapy
Number of subjects: 442
Study: 32956682

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cathodal tDCS
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study: 36229112

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Intervention (n=19)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Supportive Psychotherapy (n=25)
Number of subjects: 44
Study: 32691125

Group type: EXPERIMENTAL
Intervention: AiMAR 4
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: AiMAR 5
Number of subjects: 25

Group type: COMPARATOR
Intervention: Original images
Number of subjects: 25
Study: 32412145

Group type: EXPERIMENTAL
Intervention: Instructional self-talk
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Motivational self-talk
Number of subjects: 40
Study: 35971073

Group type: EXPERIMENTAL
Intervention: Care manager-led information provision and practical support
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 53
Study: 33978187

Group type: EXPERIMENTAL
Intervention: 60 mg elemental iron as ferrous sulfate for 12 weeks
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Hb as measured with a hematology analyzer
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Inflammation-adjusted ferritin
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Hepcidin
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Inflammation-adjusted total body iron stores (TBIS)
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Combined predictive ability of Hb (hematology analyzer), inflammation-adjusted ferritin, and hepcidin
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Hb measured with the HemoCue
Number of subjects: 407
Study: 32942935

Group type: EXPERIMENTAL
Intervention: PD‐LTF+ group (19 patients)
Number of subjects: 38

Group type: COMPARATOR
Intervention: PD‐LTF- group (19 patients)
Number of subjects: 38
Study: 33663545

Group type: EXPERIMENTAL
Intervention: Betaine supplementation (2 g/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo group (PG)
Number of subjects: 29
Study: 35094931

Group type: EXPERIMENTAL
Intervention: Progressive tendon-loading exercise therapy
Number of subjects: 76

Group type: COMPARATOR
Intervention: Eccentric exercise therapy
Number of subjects: 76
Study: 33605796

Group type: EXPERIMENTAL
Intervention: Triple bolus computerized tomography
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional computerized tomography
Number of subjects: 200
Study: 33368114

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg daily for 45 days
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 85
Study: 36259883

Group type: EXPERIMENTAL
Intervention: Axillary reverse mapping and selective axillary dissection (ARM-SAD)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard axillary dissection (AD)
Number of subjects: 130
Study: 33043344

Group type: EXPERIMENTAL
Intervention: Intraoral ultrasonic imaging
Number of subjects: 18
Study: 35318115

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (administered at birth, 1 month, and 6 months)
Number of subjects: 82366

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 82366

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine
Number of subjects: 82366
Study: 32762513

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 177
Study: 34544780

Group type: EXPERIMENTAL
Intervention: Physical examination and a two-point PoCUS scan
Number of subjects: 1206

Group type: COMPARATOR
Intervention: Physical examination only
Number of subjects: 1206
Study: 36328489

Group type: EXPERIMENTAL
Intervention: Conventional imaging plus 18F-fluciclovine PET/CT (arm B)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Conventional imaging only (arm A)
Number of subjects: 157
Study: 33330915

Group type: EXPERIMENTAL
Intervention: Leucine intake ranging from 20 to 120 mg . kg‐1 . d‐1
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Leucine intake based on fat-free mass
Number of subjects: 16
Study: 35709830

Group type: EXPERIMENTAL
Intervention: 30 g of donor feces
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: 60 g of donor feces
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 33676533

Group type: EXPERIMENTAL
Intervention: Covariate-constrained randomization (CCR) methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Values of I below the 10th percentile
Number of subjects: 0
Study: 32284450

Group type: EXPERIMENTAL
Intervention: Concurrent resistance-aerobic training for 16 weeks, 60 min three times a week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 36175740

Group type: EXPERIMENTAL
Intervention: STOPP/START
Number of subjects: 123

Group type: COMPARATOR
Intervention: PIM-Check
Number of subjects: 123
Study: 32959481

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive-behavioural therapy (ICBT) with brief weekly telephone support
Number of subjects: 68

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: ICBT group
Number of subjects: 68
Study: 32164773

Group type: EXPERIMENTAL
Intervention: Comprehensive corrective exercises program (CCEP) conducted three times a week for 8 weeks, followed by 4 weeks of detraining
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group doing their daily activities
Number of subjects: 22
Study: 35287166

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nicotine patch
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nicotine patch + mini‐lozenge
Number of subjects: 0
Study: 32087841

Group type: EXPERIMENTAL
Intervention: MICUNAY (Motivational Interviewing and Culture for Urban Native American Youth) + CWG (Community Wellness Gathering)
Number of subjects: 185

Group type: COMPARATOR
Intervention: CWG (Community Wellness Gathering) only
Number of subjects: 185
Study: 35924071

Group type: EXPERIMENTAL
Intervention: Experimental group with injection speeds of 2.3/2.4/2.5/2.6/2.7/2.8/2.9 ml/s and 350 mgI/ml contrast agents, injection time fixed at 10 s.
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control group with a fixed injection flow rate of 3.5 ml/s, time was 12 s with a total of 42 ml.
Number of subjects: 280
Study: 33847663

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 0
Study: 34776152

Group type: EXPERIMENTAL
Intervention: XBOX (n = 15)
Number of subjects: 29

Group type: COMPARATOR
Intervention: CONTROL (n = 14)
Number of subjects: 29
Study: 34180947

Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 34544904

Group type: EXPERIMENTAL
Intervention: Dynamic Stretching (DS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dynamic Stretching followed by Foam Rolling (DS + FR)
Number of subjects: 30
Study: 32732154

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (3,666 mg/day for 3 months)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Corn oil supplement (control)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 100
Study: 32200051

Group type: EXPERIMENTAL
Intervention: Home-based non-weight bearing (NWB) quadriceps strengthening
Number of subjects: 128

Group type: COMPARATOR
Intervention: Weight bearing (WB) functional exercise
Number of subjects: 128
Study: 35815079

Group type: EXPERIMENTAL
Intervention: Coronally advanced flap with Biomesh® membrane
Number of subjects: 20

Group type: COMPARATOR
Intervention: Coronally advanced flap only
Number of subjects: 20
Study: 34132697

Group type: EXPERIMENTAL
Intervention: Enhanced feedback
Number of subjects: 2624

Group type: COMPARATOR
Intervention: Standard PRO monitoring
Number of subjects: 2624
Study: 32239498

Group type: EXPERIMENTAL
Intervention: High plant α-diversity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermediate plant α-diversity in six-plot combinations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High plant α-diversity in six-plot combinations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Homogeneous plant α-diversity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Varying heterogeneity in six-plot combinations
Number of subjects: 0
Study: 36151529

Group type: EXPERIMENTAL
Intervention: Training GPs to offer treatment as the default choice using an encounter decision aid (paper or electronic).
Number of subjects: 106

Group type: COMPARATOR
Intervention: Enhanced usual care group receives a brief refresher training about smoking cessation without changing their behaviour.
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Consulting a GP who received the intervention.
Number of subjects: 106
Study: 32476455

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention to decrease sedentary time (includes paper and digital information, exercise movie, activity planner, pedometer and Fitbit Flex™, personal activity coach, individualized digital training program)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Usual care (control phase)
Number of subjects: 94
Study: 35238084

Group type: EXPERIMENTAL
Intervention: NST plus AMX + MTZ
Number of subjects: 37

Group type: COMPARATOR
Intervention: NST alone
Number of subjects: 37
Study: 34586338

Group type: EXPERIMENTAL
Intervention: Skeletonized ITA
Number of subjects: 2161

Group type: COMPARATOR
Intervention: Pedicled ITA
Number of subjects: 2161
Study: 35716471

Group type: EXPERIMENTAL
Intervention: Gyejibongnyeong-Hwan (GBH) treatment for 8 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Gyejibongnyeong-Hwan (GBH) treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wait-List group
Number of subjects: 40
Study: 33823028

Group type: EXPERIMENTAL
Intervention: Push intervention (16 weeks of lower extremity strengthening, function, and endurance training)
Number of subjects: 89
Study: 36349190

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lumbar plexus block (group L)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Transversus abdominis plane block (group T)
Number of subjects: 80
Study: 33188075

Group type: EXPERIMENTAL
Intervention: Sequential two-step cell-based assay measuring TNF-α production by CD14+16+ intermediate monocytes after EBV peptide stimulation
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Assay based on examination of early mature B (eBm5) cells
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Sequential cell-based assay examining monocyte and eBm5 cell response to EBV peptides
Number of subjects: 87
Study: 35031013

Group type: EXPERIMENTAL
Intervention: Gestational diabetes mellitus (GDM) treatment
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Prediabetes at the time of confirmation of pregnancy
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Age and BMI
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Maternal height
Number of subjects: 19
Study: 34147308

Group type: EXPERIMENTAL
Intervention: Telehealth-delivered dietary counseling via telephone
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Telehealth-delivered dietary counseling via telephone (direct contact with patient)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Telehealth-delivered dietary counseling via telephone (contact through nursing homes)
Number of subjects: 156
Study: 32916607

Group type: EXPERIMENTAL
Intervention: Alogliptin
Number of subjects: 5380

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5380
Study: 34507360

Group type: EXPERIMENTAL
Intervention: Pulsatile jet lavage
Number of subjects: 20

Group type: COMPARATOR
Intervention: Syringe lavage
Number of subjects: 20
Study: 32974931

Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 337

Group type: COMPARATOR
Intervention: Education
Number of subjects: 337
Study: 34596714

Group type: EXPERIMENTAL
Intervention: Classical music ratings
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Jazz music ratings
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Soul music ratings
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: STARR test
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Matrix test
Number of subjects: 20
Study: 34310464

Group type: EXPERIMENTAL
Intervention: rAAV2/2‐ND4 gene therapy
Number of subjects: 76
Study: 1986130709

Group type: EXPERIMENTAL
Intervention: High-salt diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-salt diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control periods (usual diet)
Number of subjects: 0
Study: 34991693

Group type: EXPERIMENTAL
Intervention: counseling + EC for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: counseling + nicotine replacement therapy (NRT) for 12 weeks
Number of subjects: 60
Study: 32265094

Group type: EXPERIMENTAL
Intervention: Digital monitoring of sleep, meals, and physical activity for 12 weeks
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Digital monitoring plus health coaching for 12 weeks
Number of subjects: 57

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 57
Study: 34526482

Group type: EXPERIMENTAL
Intervention: Expectancy manipulation
Number of subjects: 0
Study: 32235281

Group type: EXPERIMENTAL
Intervention: Robot-assisted radical cystectomy (RARC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open radical cystectomy (ORC)
Number of subjects: 0
Study: 36030390

Group type: EXPERIMENTAL
Intervention: Asundexian 10 mg
Number of subjects: 1601

Group type: EXPERIMENTAL
Intervention: Asundexian 20 mg
Number of subjects: 1601

Group type: EXPERIMENTAL
Intervention: Asundexian 50 mg
Number of subjects: 1601

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1601
Study: 34551263

Group type: EXPERIMENTAL
Intervention: Health promotion intervention (three-session social cognitive theory-informed)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Health awareness control (one-session)
Number of subjects: 302
Study: 36461619

Group type: EXPERIMENTAL
Intervention: THRIVE (100% oxygen, 40 L/min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Facemask (100% oxygen, 6 L/min)
Number of subjects: 40
Study: 35104066

Group type: EXPERIMENTAL
Intervention: High volume resistance training (3 sets per exercise)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Low volume resistance training (1 set per exercise)
Number of subjects: 38
Study: 33068792

Group type: EXPERIMENTAL
Intervention: Androgen suppression for 6 months, starting either 4 months before or concurrently with definitive prostate radiation therapy
Number of subjects: 426
Study: 32534568

Group type: EXPERIMENTAL
Intervention: EQ-5D index
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: AQLQ
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: VAS
Number of subjects: 371
Study: 35123016

Group type: EXPERIMENTAL
Intervention: 35% HP (4 sessions, 1x/week)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Violet LED (4 sessions, 1x/week)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Violet LED (4 sessions, 2x/week)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Hybrid technique (violet LED + 35% HP; 4 sessions, 1x/week)
Number of subjects: 100
Study: 33368190

Group type: EXPERIMENTAL
Intervention: Clever Kids programme (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wait-list control condition (n=20)
Number of subjects: 40
Study: 33922507

Group type: EXPERIMENTAL
Intervention: DHA-rich tuna oil capsules (6 capsules per day) for 8 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (Sunola oil) capsules (6 capsules per day) for 8 weeks
Number of subjects: 53
Study: 33243198

Group type: EXPERIMENTAL
Intervention: LPG intervention (stove and free fuel)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Biomass cookfuel
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: LPG cookfuel
Number of subjects: 120
Study: 33009191

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine and propofol (group DP)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Propofol alone (group P)
Number of subjects: 39
Study: 32037784

Group type: EXPERIMENTAL
Intervention: Concurrent exercise with post-activation potentiation (CE-PAP)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Strength exercise (SE) only
Number of subjects: 11

Group type: COMPARATOR
Intervention: Concurrent exercise (CE)
Number of subjects: 11
Study: 35130342

Group type: EXPERIMENTAL
Intervention: Gilteritinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salvage Chemotherapy (SC)
Number of subjects: 0
Study: 32178231

Group type: EXPERIMENTAL
Intervention: Exergame group (EG) - virtually supervised intradialytic exercise program
Number of subjects: 73

Group type: COMPARATOR
Intervention: Supervised exercise group (SG) - nurse-supervised intradialytic exercise
Number of subjects: 73
Study: 34998232

Group type: EXPERIMENTAL
Intervention: Virtual shopping training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 32
Study: 34129715

Group type: EXPERIMENTAL
Intervention: Cotton
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene (PTFE)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Synthetic foam
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Polyvinyl siloxane (PVS)
Number of subjects: 8
Study: 32859607

Group type: EXPERIMENTAL
Intervention: rtCGM (Guardian Connect Mobile)
Number of subjects: 60

Group type: COMPARATOR
Intervention: isCGM (FreeStyle Libre)
Number of subjects: 60
Study: 33664157

Group type: EXPERIMENTAL
Intervention: TIMP+MI
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: TIMP
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: TIMP+cMI
Number of subjects: 30
Study: 33148720

Group type: EXPERIMENTAL
Intervention: Enhanced 6-month intervention package (one face-to-face physiotherapy assessment, tailored physical activity plan, physical activity phone coaching from a physiotherapist, informational/motivational resources and activity monitors)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Less intensive 6-month intervention package (single session of tailored phone advice from a physiotherapist, tailored physical activity plan, unidirectional text messages, informational/motivational resources)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Enhanced intervention package
Number of subjects: 600

Group type: COMPARATOR
Intervention: Less intensive intervention package
Number of subjects: 600
Study: 35110309

Group type: EXPERIMENTAL
Intervention: Stand-alone mobile mindfulness app for 3 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 60
Study: 34582701

Group type: EXPERIMENTAL
Intervention: Yoga therapy (asana and pranayama practice for 12 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral antidiabetic drugs (OAD) alone
Number of subjects: 80